Patents Assigned to Shepherd Therapeutics, Inc.
  • Patent number: 10933061
    Abstract: The disclosure relates to a method of treating cancer by administering to the subject a therapeutically effective amount of a composition comprising pyrvinium pamoate, optionally in combination with at least one additional therapeutic agent or modality.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: March 2, 2021
    Assignee: Shepherd Therapeutics, Inc.
    Inventors: Katherine Arline, Jamie Dempsey Barber, William M. Siders, Johanne Kaplan